Advances in Oncology in US and Japan: Focusing on Cancer and Infectious Diseases.

Career development Clinical trials CoRe Partnership Immunotherapy Infectious diseases Oncogenesis Oncology Translational research

Journal

World journal of oncology
ISSN: 1920-454X
Titre abrégé: World J Oncol
Pays: Canada
ID NLM: 101564097

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 05 10 2021
accepted: 02 12 2021
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 22 1 2022
Statut: ppublish

Résumé

This is a review article based on the international symposium report of the "US-Japan Conference on Advances in Oncology: Cancer and Infectious Diseases" held online on June 25, 2021, which provided an update on the association between oncology and infectious disease research from cutting-edge basic science to high-impact clinical trials.

Identifiants

DOI: 10.14740/wjon1422 PMID: 35059078 PMC: PMC8734503
pubmed: 35059078
doi: 10.14740/wjon1422
pmc: PMC8734503
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

183-194

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

Copyright 2021, Nakano et al.

Déclaration de conflit d'intérêts

Y.Y.J. has received research funding provided to her institution from Bayer, Bristol-Myers Squibb, Cycle for Survival, Department of Defense, Eli Lilly, Fred’s Team, Genentech/Roche, Merck, NCI, and RGENIX. She has performed advisory boards/consulting activities for Astra Zeneca, Basilea Pharmaceutica, Bayer, Bristol-Myers Squibb, Daiichi-Sankyo, Eli Lilly, Imugene, Merck, Merck Serono, Michael J. Hennessy Associates, Paradigm Medical Communications, Pfizer, RGENIX, Seagen, and Zymeworks Inc. She has stock option interest with RGENIX. All other authors declare no competing interests.

Références

J Exp Med. 1910 Sep 1;12(5):696-705
pubmed: 19867354
J Thorac Oncol. 2021 Oct 12;:
pubmed: 34648948
Gastric Cancer. 2019 May;22(3):527-535
pubmed: 30386954
Sci Transl Med. 2019 Jan 16;11(475):
pubmed: 30651320
Sci Immunol. 2021 Jan 15;6(55):
pubmed: 33452107
PLoS Pathog. 2016 May 31;12(5):e1005667
pubmed: 27244558
Nat Commun. 2021 Jan 28;12(1):668
pubmed: 33510133
Cell Res. 2020 Jun;30(6):507-519
pubmed: 32467593
Future Oncol. 2021 Feb;17(5):491-501
pubmed: 33167735
Lancet. 1964 Mar 28;1(7335):702-3
pubmed: 14107961
BMC Infect Dis. 2014 Apr 29;14:229
pubmed: 24775713
Sci Rep. 2021 Mar 10;11(1):5563
pubmed: 33692457
Glob Health Med. 2020 Dec 31;2(6):343-345
pubmed: 33409412
Sci Rep. 2017 Aug 31;7(1):10188
pubmed: 28860565
J Virol. 2021 Nov 24;:JVI0155121
pubmed: 34818068

Auteurs

Hiroto Nakano (H)

Translational Genetics and Genomics Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

Takuto Miyamoto (T)

Washington, D.C. Office, Japan Agency for Medical Research and Development (AMED), District of Columbia, USA.
Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan.

Yelena Y Janjigian (YY)

Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Sohtaro Mine (S)

Medical Virology Section, Laboratory of Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Hiroaki Mitsuya (H)

Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
Department of Clinical Sciences, Kumamoto University Hospital, Kumamoto, Japan.

Naoto T Ueno (NT)

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Elad Sharon (E)

Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

Shunsuke Sakai (S)

T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

William C Timmer (WC)

Cancer Therapy Evaluation Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.

Shuichiro Nakabo (S)

Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

Tomoko Ikeuchi (T)

Oral Immunology and Inflammation Section, National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

Saori Fujiwara (S)

Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Minori Kinjo (M)

Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.

Tadashi Inuzuka (T)

Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

Hayato Kume (H)

Embassy of Japan in the USA.

Keisuke Shirai (K)

Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.

Norihiro Yamaguchi (N)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY 10065, USA.

Kazuaki Takabe (K)

Breast Surgery, Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Department of Surgery, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, The State University of New York, Buffalo, NY 14263, USA.
Department of Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo 160-8402, Japan.
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Department of Breast Surgery, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.

Naoko Takebe (N)

Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.

Classifications MeSH